1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
InnSuites Hospitality Trust said NYSE American accepted its compliance plan and granted a plan period through December 24, 2027. The Trust is not currently in compliance with NYSE American continued listing standards, but its listing continues under the extension, and staff could start delisting proceedings if the Trust does not meet the standards or make progress under the plan.
NYSE American notice received September 10, 2026; plan period runs through December 24, 2027
Trust increased stockholders' equity by $3 million on August 19, 2026, as one step toward compliance
Consolidated net income for the Fiscal First Quarter was $74,702, up 48% from the prior year quarter
Filing states there is no assurance the Trust will regain compliance or complete any proposed transaction
Radiant Logistics reported fourth-quarter results for the three months ended June 30, 2026, with revenue of $261.4 million, up 18.5%, and GAAP net income attributable to the company of $7.5 million, up 53.1%. For the full fiscal year, GAAP net income rose to $18.8 million, but adjusted EBITDA fell to $36.7 million from $38.8 million and adjusted net income fell to $25.3 million from $30.9 million, so shareholders see stronger quarterly growth alongside lower full-year adjusted profit.
Q4 revenue $261.4 million, up $40.8 million or 18.5%; Q4 diluted EPS $0.15 versus $0.10 a year earlier
Q4 adjusted EBITDA $10.4 million, up 31.6%; adjusted EBITDA margin 15.5%, up 240 basis points
Full-year revenue $934.4 million versus $902.7 million; full-year adjusted EBITDA $36.7 million versus $38.8 million
On August 7, 2026, the $200 million revolving credit facility was extended to August 7, 2031; the company reported no net debt as of June 30, 2026
On September 14, 2026, Plains All American Pipeline, L.P. (PAA), a wholly owned subsidiary of PAGP, completed a public offering of $700 million of 6.750% Series A notes and $800 million of 7.000% Series B notes, both due December 15, 2056. The notes are unsecured, rank junior to PAA's existing and future senior debt, and are not guaranteed by PAA's subsidiaries. The filing also provides unaudited pro forma 2025 results that show revenue slightly higher but per-share net income from continuing operations lower than reported, reflecting the EPIC Crude Holdings acquisitions.
Series A: $700 million, 6.750% junior subordinated notes due December 15, 2056; interest first payable June 15, 2027.
Series B: $800 million, 7.000% junior subordinated notes due December 15, 2056; rates may reset on December 15, 2036 and every five years after.
Pro forma 2025 revenue of $44,464 million versus $44,262 million historical; net income per Class A share of $0.68 versus $0.77 historical.
Underwriters were J.P. Morgan Securities LLC, Citigroup Global Markets Inc., Mizuho Securities USA LLC, MUFG Securities Americas Inc. and Truist Securities, Inc.
Boxlight received a Nasdaq Hearings Panel decision on September 2, 2026 that it has regained compliance with the $2.5 million stockholders' equity requirement and may continue listing on Nasdaq. The Panel also imposed a one-year monitoring period, so any future Nasdaq rule noncompliance could lead directly to a delisting determination without a cure period.
Panel decision dated September 2, 2026 found compliance with the $2,500,000 stockholders' equity rule (Rule 5550(b)(1)).
Compliance plan relied on a Series D preferred financing: $4.8 million raised in Tranche One on August 5, 2026, with about $6.6 million in net proceeds for the full PIPE transaction.
One-year Discretionary Panel Monitor effective August 17, 2026; any new noncompliance may lead to a Delist Determination Letter.
Review of the decision may be requested within 15 calendar days, subject to a $15,000 fee.
CubeSmart filed an investor presentation with its 8-K that shows year-to-date 2026 same-store results through June 30, 2026, including revenue growth of 0.7%, expense growth of 5.1%, and a 1.1% decline in same-store net operating income. The full-year 2026 outlook shown was last updated in the July 30, 2026 earnings release, and the filing does not state a new change to it. The deck also reports second-quarter FFO, as adjusted, of $0.63 per share and share repurchases of 2.0 million shares for $75.8 million.
Sionna Therapeutics said its Board approved a restructuring on September 9, 2026, that cuts about 46% of its workforce and winds down the SION-719 add-on program, with aggregate charges currently estimated at about $6.4 million. The company said the changes are meant to focus resources on the SION-451 and SION-2222 dual combination and extend its cash runway into the second half of 2029. Its Chief Business Officer's employment is ending, and the company is repricing employee stock options.
Restructuring charges are estimated at about $6.4 million, including $5.3 million in employee severance and other post-employment benefits, $0.7 million in SION-719 contract close-out costs and $0.4 million in stock-based compensation.
Workforce reduction and vendor wind-down are expected to be substantially complete by the end of the third quarter of 2026.
The company had about $268.3 million in cash, cash equivalents and marketable securities at the end of Q2 2026, and expects its runway to extend into the second half of 2029.
Chief Business Officer Caroline Stark Beer's employment ends September 15, 2026; option repricing takes effect September 17, 2026.
Kestra Medical Technologies reported first quarter fiscal 2027 revenue of $31.0 million, up 60% from the prior year period, and raised its FY27 revenue guidance to $141 million from $137 million. The GAAP net loss widened to $44.1 million from $25.8 million, so revenue growth came with larger losses for shareholders.
Revenue was $31.0 million for the quarter ended July 31, 2026, up 60% from the prior year period; gross margin was 56.5% versus 45.7%.
GAAP net loss was $44.1 million, or $0.75 per share, compared with $25.8 million, or $0.50 per share, a year earlier.
FY27 revenue guidance was increased to $141 million, growth of 48% over FY26, from prior guidance of $137 million.
Cash, cash equivalents and investments totaled $244.7 million as of July 31, 2026; total liquidity was about $320 million including committed unused term loan availability.
Cardiff Oncology and Nerviano Medical Sciences agreed on September 14, 2026 to settle their pending litigation, with both parties dismissing the case with prejudice and exchanging mutual releases, and no monetary payment made between them. The companies also amended the 2017 license agreement for onvansertib, changing exclusivity, royalty, milestone, governance and assignment terms, which matters to shareholders because it reshapes the economics and conditions of the company's lead asset.
Settlement and Amendment dated September 14, 2026; the Amendment takes full effect when the case is dismissed with prejudice.
No monetary payment was made by either party to resolve the litigation, and neither party admitted liability.
Amendment adds an additional license fee on annual net sales of products practicing a valid Company patent claim, in lieu of the existing royalty.
If Cardiff assigns the license, including by merger or change of control, before Phase III data readout, it would owe Nerviano a percentage of transaction proceeds based on Phase III dosing timing.
Future Vision II Acquisition Corp. issued a $65,000 non-interest-bearing promissory note to its sponsor, Hwei Super Speed Co., Ltd., to fund a one-month extension of its deadline to complete a business combination, moving the date from September 13, 2026 to October 13, 2026. The note is forgiven if no business combination is completed, and the company states there is no assurance it will close a deal by October 13, 2026.
Promissory note of $65,000 issued September 10, 2026 to sponsor Hwei Super Speed Co., Ltd.
Business combination deadline extended from September 13, 2026 to October 13, 2026
August 2026 extension redemptions paid at $11.03 per share
Company continues to pursue its merger with MicroTouch Technology Inc. under a January 16, 2026 agreement
In an investor update for the Barclays Global Financial Services Conference, PennyMac Financial said its production segment pretax income is expected to be lower than in 2Q26, mainly due to lower pull-through adjusted lock volume after mortgage rates rose 50 basis points from June 30. It expects servicing segment pretax income to be higher than 2Q26, while corporate pretax loss is expected to be similar to 3Q25, so shareholders face a mix of weaker production and stronger servicing expectations.
Total acquisitions and originations were $16.6 billion quarter-to-date through 8/31/26, versus $34.9 billion in 2Q26.
Production revenue margin is expected at 75 to 85 basis points, compared with 77 basis points in 2Q26.
Servicing realization of MSR cash flows is expected to decline 10% or more due to lower prepayment speeds.
Owned servicing portfolio was $503 billion in unpaid principal balance, up from June 30.
On September 10, 2026, AirJoule Technologies, a subsidiary of AirJoule Technologies Corporation, acquired all equity of Bitsink LLC, a South Carolina maker of cooling, power distribution and racking infrastructure for data centers. The upfront price was $18 million in cash, subject to adjustments, plus 1,859,504 shares of Class A common stock, with up to $40 million more in stock payable if 2027 to 2029 revenue targets are met.
Upfront consideration: $18 million in cash (subject to certain adjustments) and 1,859,504 shares of Class A common stock issued to seller Stanislav Dyshko.
Earnout: up to $40 million payable in Class A common stock if revenue targets are achieved during 2027 through 2029; maximum of 8,264,463 additional shares.
AirJoule Technologies had $45 million of cash on the balance sheet on August 31, 2026, before the transaction.
The press release says Bitsink had cumulative revenue of approximately $11 million across 2024 and 2025.
Hain Celestial agreed on September 12, 2026 to sell its International business in the UK, Ireland and Europe to affiliates of AURELIUS, with estimated net proceeds of $305 million to $310 million to be used to reduce debt. Closing depends on regulatory approvals and a credit agreement amendment by October 12, 2026, which the company says it is still negotiating with lenders. The same day it reported fiscal fourth-quarter net sales down 28% to $263 million, with a narrower net loss of $62 million.
Gross sale price of £233.0 million plus an estimated £5.5 million locked box amount, about $323.2 million in total; expected net cash proceeds of $305 million to $310 million
Closing requires a credit agreement amendment by October 12, 2026 extending the December 22, 2026 maturity by at least nine months; the purchasers may terminate if it is not obtained
Expected closing in the fiscal second quarter ending December 31, 2026
Fiscal Q4 2026 net sales $263 million, down 28%; net loss $62 million versus $273 million; loss per diluted share $0.68 versus $3.06
WhiteFiber filed an investor presentation dated September 2026 under Regulation FD. It reports Q2 2026 total revenues of $28.8 million, up from $18.7 million a year earlier, while the net loss widened to $15.0 million from $8.8 million. The deck also highlights a 10-year, 40 MW Nscale contract valued at about $865 million and a $60 million North Carolina site acquisition agreement.
Q2 2026 total revenues were $28.8 million versus $18.7 million in Q2 2025.
Q2 2026 net loss was $15.0 million versus $8.8 million in Q2 2025; Adjusted EBITDA was $5.5 million versus $3.3 million.
NC-1 anchor contract with Nscale: 10 years, 40 MW IT load, total contract value about $865 million.
Definitive agreement signed August 16, 2026 to buy two North Carolina properties for $60 million in cash, with closing expected in Q4 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.